Matthias D'Huyvetter

Academic, Supporting clinical sciences
Medical Imaging

Laarbeeklaan 101
1090 Brussels
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Matthias D'Huyvetter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

3 Active
6 Finished

FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.
1/11/19 → 31/10/21
Project: Fundamental
SRP62: SRP-Groeifinanciering: Single-domain antibody fragment (SdAb)-based TArgeted Radionuclide Therapy: STaRT programme
Keyaerts, M., D'Huyvetter, M. & Neyns, B.
1/03/19 → 29/02/24
Project: Fundamental
FWOTM838: Nanobody-based theranostics in cancer therapy.
D'Huyvetter, M.
1/10/15 → 30/09/21
Project: Fundamental
FWOUW25: Visiting Polish researcher prof. Magdalena Rodak (22-28 september 2019)
D'Huyvetter, M.
22/09/19 → 28/09/19
Project: Fundamental
FWOUW24: Visiting Polish researcher prof. Marek Pruszynski (22 - 28 september 2019)
D'Huyvetter, M.
22/09/19 → 28/09/19
Project: Fundamental

1029 Citations
18 h-Index
27 Article
26 Poster
18 Meeting abstract (Book)
6 Unpublished abstract
More

Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 Feb 2020, p. page 79. 1 p.
Research output: Unpublished contribution to conference › Poster
Multi-regional dosimetry of mouse kidneys for beta-emitters
Vargas, C. S., Covens, P., D'Huyvetter, M., Caveliers, V., Miller, B. W. & Struelens, L., Sep 2020, In : European Journal of Nuclear Medicine and Molecular Imaging. 47, SUPPL 1, p. S57-S57
Research output: Contribution to journal › Meeting abstract (Journal)
Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
D'Huyvetter, M., De Vos, J., Caveliers, V., Vaneycken, I., Heemskerk, J., Duhoux, F. P., Fontaine, C., Vanhoeij, M., Windhorst, A. D., van der Aa, F., Hendrikse, N. H., Eersels, J. L. E., Everaert, H., Gykiere, P., Devoogdt, N., Raes, G., Lahoutte, T. & Keyaerts, M., 4 Dec 2020, In : Journal of Nuclear Medicine.
Research output: Contribution to journal › Article
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Windhorst, A. D., van der Aa, F., Lecocq, Q., Breckpot, K., Morgenstern, A., Bruchertseifer, F., Lahoutte, T., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, p. 1017
Research output: Contribution to journal › Article
5 Citations (Scopus)
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.
Research output: Contribution to journal › Article

Open Access
File
18 Downloads (Pure)

Alavi-Mandell Award from Journal of Nuclear Medicine
Ahmet Krasniqi (Recipient), Matthias D'Huyvetter (Recipient), Nick Devoogdt (Recipient) & Marleen Keyaerts (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
Award of the Fonds Germaine Eisendrath Dubois (FGED)
Matthias D'Huyvetter (Recipient), 2012
Prize: Prize (including medals and awards)
Fellowship Award BAEF
Matthias D'Huyvetter (Recipient), 2011
Prize: Fellowship awarded competitively
Poster Award
Matthias D'Huyvetter (Recipient), 2011
Prize: Prize (including medals and awards)
Travel Award of Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)
Matthias D'Huyvetter (Recipient), 7 Sep 2016
Prize: Prize (including medals and awards)

13 Talk or presentation at a conference
7 Talk or presentation at a workshop/seminar
5 Talk at an external academic organisation
4 Other

2021-83
Vicky Caveliers (Supervisor), Matthias D'Huyvetter (Contributor)
2021
Activity: Other
2021-32
Matthias D'Huyvetter (Supervisor), Catarina Xavier (Contributor)
2021
Activity: Other
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor), Yana Dekempeneer (Contributor)
2020
Activity: Other
2019-68
Vicky Caveliers (Supervisor), Matthias D'Huyvetter (Contributor), Laurent Navarro (Contributor)
2019
Activity: Other
An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer
Matthias D'Huyvetter (Contributor), Jens De Vos (Contributor), Catarina Xavier (Contributor), Marek Pruszynski (Contributor), Yann Sterckx (Contributor), Sam Massa (Contributor), Geert Raes (Contributor), Vicky Caveliers (Contributor), Michaël Zalutsky (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Speaker)
21 Mar 2018
Activity: Talk or presentation › Talk or presentation at a conference

Camel blood to fight cancer? This VUB spin-off is getting amazing results
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/11/17
1 Media contribution
Press/Media: Research
Kanker bestrijden met elektrische fietsjes in het bloed
Tony Lahoutte, Ruth Devenyns, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/10/17
1 Media contribution
Press/Media: Research
Lama-antistoffen in strijd tegen kanker
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
30/03/17
1 Media contribution
Press/Media: Research
Wat is borstkanker en hoe wordt deze ziekte behandeld?
Matthias D'Huyvetter
27/02/17
1 Media contribution
Press/Media: Research
Press release spin-off Camel-IDS and interaction with VUB/UZ Brussel
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
2 items of Media coverage
Press/Media: Public Engagement Activities

CD20 Nb TRNT : targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Author: Devoogdt, N., D'Huyvetter, M. & Tavernier, J., 2019
Student thesis: Doctoral Thesis
EGFRvIII Nb TRNT: Evaluation of radiolabeled nanobodies for the treatment of cancers expressing mutant EGFR’
Author: Puttemans, J., Devoogdt, N., D'Huyvetter, M. & Muyldermans, S., 2020
Student thesis: Doctoral Thesis
Evaluation of anti-idiotype Nanobodies in a preclinical model of Multiple Myeloma
Author: Sharma, P., Puttemans, J., Devoogdt, N., D'Huyvetter, M. & Muyldermans, S., 2019
Student thesis: Master's Thesis
Evaluation of TRNT-mediated immunogenic effects
Author: Krasniqi, A., Hugé, H. L. S., D'Huyvetter, M. & Raes, G., 2020
Supervisor: Krasniqi, A. (Advisor)
Student thesis: Master's Thesis
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Author: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 Jun 2019
Supervisor: Krasniqi, A. (Promotor)
Student thesis: Master's Thesis